In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line

Wei Xu(Huazhong University of Science and Technology), Julia K. MacCallum(University of Wisconsin–Madison), Jie Tian(University of Science and Technology of China), Jack J. Jiang(Stony Brook University), Liang Zhou(Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine), Lei Cheng(Fudan University)
Head & Neck
October 13, 2008
10.1002/hed.20935
Cited by 92

Related Papers

Reversibly Switching Bilayer Permeability and Release Modules of Photochromic Polymersomes Stabilized by Cooperative Noncovalent Interactions
|Journal of the American Chemical Society|2015|293
CD133, One of the Markers of Cancer Stem Cells in Hep‐2 Cell Line
|The Laryngoscope|2007|125
Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain
|Cancer Letters|2013|75
In vivo synthesis of nano-selenium by Tetrahymena thermophila SB210
|Enzyme and Microbial Technology|2016|55
Characterization of selective exosomal microRNA expression profile derived from laryngeal squamous cell carcinoma detected by next generation sequencing
|Oncology Reports|2018|55